Fate Therapeutics raises $30 million

Fate Therapeutics Inc. (La Jolla, Calif.) raised $30 million in a series B round led by existing investor OVP Venture Partners. New investors Astellas Venture; Genzyme Ventures; and an undisclosed corporate investor joined existing investors Arch Venture Partners; Polaris Venture Partners; and Venrock. ...